Detalhe da pesquisa
1.
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Blood
; 134(5): 432-444, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151986
2.
A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.
Blood
; 132(5): 521-532, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29743179
3.
A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.
Blood
; 117(20): 5463-72, 2011 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21385850
4.
Antibody-based therapeutics for the treatment of human B cell malignancies.
Curr Allergy Asthma Rep
; 13(1): 33-43, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23229130
5.
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.
Clin Cancer Res
; 29(18): 3612-3621, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227160
6.
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Blood
; 116(22): 4532-41, 2010 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702778
7.
A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.
Blood
; 114(20): 4494-502, 2009 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-19667400
8.
Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
Clin Cancer Res
; 27(16): 4624-4633, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875521
9.
Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
Clin Cancer Res
; 14(2): 396-404, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18223214
10.
Siglec-6 on Chronic Lymphocytic Leukemia Cells Is a Target for Post-Allogeneic Hematopoietic Stem Cell Transplantation Antibodies.
Cancer Immunol Res
; 6(9): 1008-1013, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29980538
11.
Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.
J Clin Invest
; 113(10): 1498-510, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15146248
12.
ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
Leuk Res
; 118: 106872, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640397
13.
Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 22(2): 459-69, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26240275
14.
Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
Clin Cancer Res
; 10(24): 8309-17, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15623607
15.
ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo.
Exp Hematol
; 43(9): 770-4.e2, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25937048
16.
In vitro priming of myeloma antigen-specific allogeneic donor T cells with idiotype pulsed dendritic cells.
Leuk Lymphoma
; 44(7): 1201-8, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12916873
17.
Targeting malignant B cells with an immunotoxin against ROR1.
MAbs
; 4(3): 349-61, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531447
18.
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies.
PLoS One
; 7(12): e52655, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23285131
19.
Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies.
PLoS One
; 6(6): e21018, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21698301
20.
The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
Cytometry B Clin Cytom
; 78 Suppl 1: S98-109, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20839343